Proximie

Bottom line

Proximie is a cloud-based operating-room platform designed for remote surgical supervision, telementoring, and video-based training. It streams multiple camera feeds simultaneously, allows remote annotation and guidance in real time, and positions itself as augmented reality infrastructure for surgical education. Best fit: academic medical centers with active robotic surgery or ENT training programs, institutions seeking remote expert consultation during complex cases, and surgical departments adapting to pandemic-era distancing protocols.

Pricing is enterprise-negotiated with no public rate card. Expect facility-level or per-OR licensing, likely starting in the mid-five figures annually for smaller programs and scaling with use. The evidence base is narrow: five PubMed-indexed studies, mostly observational and concentrated in robotic prostatectomy and ENT workflows. Zero mentions in clinician forums (Reddit, Doximity public threads), which limits independent validation of real-world performance and satisfaction.

Verdict: Proximie addresses a genuine need in surgical training and remote expertise access, with documented utility in controlled academic settings. However, the thin evidence base, complete pricing opacity, and absence of independent clinician discussion warrant a cautious, pilot-based approach rather than system-wide deployment. Institutions should demand clear ROI projections, contract flexibility, and measurable training outcomes before committing to multi-year agreements.

Why we picked it

Proximie represents the category of surgical telepresence platforms purpose-built for the operating room, a niche that grew substantially during COVID-19 and has persisted as training models shift toward hybrid and remote modalities. Unlike general telehealth platforms retrofitted for surgical use, Proximie was designed from the ground up to handle the unique demands of intraoperative video streaming: multiple simultaneous camera angles (surgical console, overhead OR camera, endoscopic feed, assistant tablet), low-latency annotation overlays, and workflow integration with robotic and minimally invasive procedures.

The platform earned attention in peer-reviewed surgical literature for its application in medical student education (Ann R Coll Surg Engl 2024) and robotic surgery workflow optimization (Int Braz J Urol 2022). These publications, while limited in scope, demonstrate that the tool has achieved measurable adoption in academic centers where training is a core mission. The ability to bring remote experts into live cases without physical travel addresses a real pain point: geographic barriers to subspecialty mentorship, especially in community hospitals or programs building new robotic capabilities.

That said, Proximie is not a dominant market leader with extensive third-party validation. It competes in a fragmented space where virtual reality simulation (Osso VR), procedure-guide apps (Touch Surgery, now Digital Surgery), and video-library platforms (Giblib) each claim adjacent territory. Proximie's differentiator is live, synchronous OR presence: the remote expert sees what the surgeon sees, annotates in real time, and can guide decision-making as the case unfolds. This positions it as a telementoring tool rather than a pre-operative training simulator.

We included it here because it represents a category that CMIOs and surgical leaders are evaluating actively, and because the evidence base, though thin, is entirely surgical and therefore relevant to decision-makers in that domain. The absence of marketing hype in the published literature is notable: the studies describe practical use cases (student visibility, robotic training, workflow optimization) rather than aspirational claims about AI transformation. For a category prone to overstatement, that restraint is worth acknowledging.

What it does well

Proximie excels at solving the visibility problem in surgical training. Medical students and junior residents often struggle to see the operative field during live cases, particularly in minimally invasive or robotic procedures where the primary surgeon works at a console and trainees observe on secondary monitors. Proximie streams the surgeon's view to remote or in-room participants on tablets or workstations, and the platform allows the attending surgeon or remote expert to annotate directly on the shared video feed. A study in Ann R Coll Surg Engl 2024 found that medical students using Proximie for ENT cases reported improved understanding of anatomy and reduced anxiety about the OR environment, both of which are persistent barriers to surgical education.

The platform supports up to four simultaneous camera feeds, which can include the robotic console view, an overhead OR camera, an assistant's tablet feed, and an external endoscopic camera. This multi-angle capability is valuable for complex cases where spatial orientation and anatomical context matter. In robotic-assisted radical prostatectomy (RARP), a procedure documented in multiple Proximie studies, the ability to display the console view alongside pelvic anatomy references and prior imaging helped novice surgeons internalize procedural steps more effectively than single-camera observation (Int Braz J Urol 2022).

Proximie's COVID-19 validation is a practical strength. During redeployment and OR capacity restrictions, the platform allowed supervising surgeons to mentor from outside the sterile field or even from off-site locations, reducing physical crowding in the OR while preserving educational continuity. A 2022 study in J Robot Surg evaluated novice users' ability to adopt the platform and found that technical proficiency developed quickly, with most users comfortable navigating the interface within a single case. This low learning curve matters in high-stakes environments where workflow friction can undermine adoption.

The platform's video-labeling and archival features support post-case review and AI training applications. One study (J Robot Surg 2023) described using Proximie-captured video to train novice surgeons on RARP procedural steps, with labeled segments enabling structured feedback sessions. The same study noted that the dataset could, in principle, feed machine-learning models for surgical workflow recognition, though no such models have been validated in published literature. The archival function also supports quality assurance, complication review, and medicolegal documentation, use cases that extend beyond training into operational risk management.

Where it falls short

The evidence base for Proximie is concerningly thin. Five PubMed-indexed studies over three years, with four concentrated in robotic surgery and one in ENT, do not constitute robust validation for a platform marketed across surgical specialties. None of the studies are randomized controlled trials; all are observational case series, platform evaluations, or narrative reviews. This limits confidence in generalizability. A CMIO evaluating Proximie for a multi-specialty surgical program has no peer-reviewed evidence that the platform performs comparably in orthopedics, cardiothoracic surgery, or neurosurgery. The vendor may have internal data, but the absence of independent, specialty-diverse validation is a red flag.

Clinician community discussion is entirely absent. Zero mentions in r/medicine, r/surgery, or r/Residency subreddits. Zero substantive threads in Doximity's public-facing forums. This silence is unusual for a platform that has been commercially available since pre-COVID and claims adoption in academic centers. By comparison, competing platforms like Osso VR and Touch Surgery generate regular clinician commentary, both positive and critical. The absence of independent user reports makes it impossible to validate vendor claims about usability, reliability, or satisfaction. Prospective buyers are forced to rely exclusively on vendor-provided references, which introduces obvious selection bias.

Pricing is entirely opaque. The vendor markets Proximie as enterprise SaaS with no public rate card, no tiered packages, and no transparent cost-per-case or cost-per-user structure. This opacity creates negotiation asymmetry: the hospital IT procurement team has no benchmark for what constitutes a fair deal, and the vendor controls all pricing levers. Hidden costs are likely: implementation fees, per-case streaming charges (if volume-based), camera hardware upgrades to meet bandwidth requirements, ongoing IT support for network optimization, and training costs for surgical staff. Without transparent pricing, ROI calculations are speculative at best.

The platform's applicability is narrow. Proximie is purpose-built for intraoperative use in surgical specialties with existing video infrastructure (robotic surgery, minimally invasive surgery, endoscopy). It offers nothing for primary care, psychiatry, radiology, pathology, or outpatient specialties. Even within surgery, its utility is concentrated in training-heavy academic environments; community hospitals with low case volumes and minimal teaching missions may struggle to justify the investment. The lack of EHR integration (addressed below) further limits its utility for clinicians who need telementoring data to flow into the medical record automatically.

Deployment realities

Deploying Proximie requires coordination across OR IT infrastructure, biomedical engineering, and surgical leadership. The platform streams high-definition video with real-time annotation overlays, which demands low-latency, high-bandwidth networking in the OR. Many hospitals operate ORs on segmented networks with strict firewall rules to isolate medical devices from enterprise IT. Proximie's cloud architecture requires whitelisting external endpoints, configuring Quality of Service (QoS) rules to prioritize video traffic, and validating that existing wifi or wired connections can sustain multi-camera streaming without packet loss. In older facilities with legacy network infrastructure, this may necessitate hardware upgrades (access points, switches, dedicated circuits) that add five-figure costs before the platform goes live.

Camera integration is another friction point. Robotic surgery consoles (da Vinci, Intuitive Surgical) have native video outputs that Proximie can tap, but integrating overhead OR cameras, assistant tablets, and external endoscopes requires adapter hardware, capture cards, or proprietary Proximie-compatible cameras. Biomedical engineering teams must validate that these integrations do not introduce latency, degrade image quality, or interfere with existing OR video-recording systems used for quality assurance. Each OR may require custom configuration depending on its equipment mix, which complicates standardization across a multi-OR facility.

Surgeon buy-in is not guaranteed. Remote annotation and live telementoring change the power dynamics of the OR: the attending surgeon's decisions become visible to off-site observers (department chairs, external consultants, quality reviewers), which some surgeons perceive as intrusive oversight rather than educational support. Training is minimal from a technical standpoint (the 2022 J Robot Surg study found novice users comfortable within one case), but cultural adoption requires framing Proximie as a training asset rather than a surveillance tool. Surgical leadership must actively sponsor the platform, model its use in their own cases, and integrate it into residency curricula to normalize adoption. Without that top-down endorsement, usage will remain sporadic and ROI will suffer.

Pricing realities

Proximie's enterprise-SaaS pricing model means every contract is individually negotiated, and public benchmarks do not exist. Based on comparable surgical-telepresence platforms, expect facility-level licensing in the range of fifty thousand to two hundred thousand dollars annually, scaling with the number of ORs enabled, case volume, and feature set (live streaming only versus archival plus AI analytics). Small academic programs (two to three robotic surgery ORs, moderate training volume) might negotiate lower entry points, but high-volume trauma centers or multi-specialty surgical institutes will face six-figure annual commitments.

Hidden costs accumulate quickly. Implementation fees (vendor-led site assessment, network configuration, camera integration, staff training) can add twenty to forty percent of first-year contract value. Ongoing IT support is non-trivial: each software update requires validation in the OR environment, network bandwidth must be monitored continuously to prevent mid-case streaming failures, and help-desk staff need training to troubleshoot Proximie-specific issues (login failures, video-feed dropouts, annotation-sync errors). If the hospital lacks in-house expertise, the vendor may require a paid support tier, adding another recurring expense. Per-case streaming fees are possible if the contract is volume-based rather than flat-rate; clarify this during negotiation to avoid surprise charges as usage scales.

Contract lock-in is a risk. Enterprise SaaS agreements typically span three to five years with auto-renewal clauses and steep early-termination penalties. If adoption underperforms (surgeons resist, training volume is lower than projected, technical issues undermine reliability), the hospital may be contractually obligated to continue paying for a platform that delivers minimal value. Insist on pilot clauses (six to twelve months, limited scope, defined success metrics) before committing to long-term agreements. ROI math should be explicit: calculate time saved per training case, reduction in travel costs for remote mentoring, and measurable improvements in resident procedural competency, then compare those benefits to total cost of ownership (licensing plus implementation plus support). Without that rigor, Proximie becomes a sunk cost justified by aspiration rather than outcomes.

Compliance + integration depth

Proximie's compliance posture is not publicly documented. The vendor website does not list HIPAA certification, SOC 2 Type II attestation, HITRUST accreditation, or FDA clearance status. For a platform streaming identifiable patient video from the OR, this opacity is problematic. HIPAA compliance is table stakes: the platform must encrypt video in transit and at rest, enforce role-based access controls to prevent unauthorized viewing, log all access events for audit trails, and execute Business Associate Agreements (BAAs) with covered entities. The absence of public compliance documentation does not mean Proximie is non-compliant, but it shifts the burden to prospective buyers to demand proof during contract negotiation. IT security teams should require third-party audit reports (SOC 2, HITRUST, ISO 27001) before approving the platform for production use.

FDA clearance status is ambiguous. Proximie is marketed as a video-streaming and telementoring platform, which may not meet the FDA's definition of a medical device if it does not directly inform diagnostic or therapeutic decisions. However, if the vendor markets AI-based surgical workflow recognition or decision-support features (hinted at in the 2023 J Robot Surg study on video labeling), FDA Class II clearance may be required. Buyers should clarify whether Proximie is registered as a medical device, whether it has 510(k) clearance for any features, and whether the vendor commits to regulatory compliance as new AI features are added. The absence of clarity here introduces regulatory risk: if FDA later determines that Proximie requires clearance and the vendor lacks it, hospitals using the platform could face compliance violations.

EHR integration is non-existent because Proximie is OR-native infrastructure, not a clinical documentation tool. It does not write notes, populate surgical reports, or sync with Epic, Cerner, or Meditech. This is appropriate for its use case (live video streaming), but it means that training data, case annotations, and post-case reviews captured in Proximie must be manually transferred to the EHR if they are to become part of the permanent medical record. For quality assurance or medicolegal purposes, this manual step introduces error risk and workflow friction. Institutions should define explicit protocols for which Proximie data must be documented in the EHR and who is responsible for that documentation (attending surgeon, resident, OR staff).

Vendor stability + roadmap

Proximie is headquartered in the United Kingdom and has operated since at least 2016 based on domain-registration records and early press coverage. The vendor survived the COVID-19 pandemic, which drove demand for remote surgical supervision, but public information about funding, leadership, or acquisition history is limited. No recent venture-capital rounds are documented in Crunchbase or PitchBook as of early 2025, which could indicate that the company is self-sustaining on revenue, has undisclosed private funding, or is operating with constrained growth capital. Prospective buyers should ask directly: Who are the investors? What is the current runway? Has the company been acquired or is an acquisition likely? Vendor instability (bankruptcy, pivot, acquisition by a larger health IT firm with different strategic priorities) could leave hospitals with an orphaned platform and no migration path.

Customer references are scarce in public documentation. The peer-reviewed studies cite academic centers in the UK and Europe, but no North American health systems are named in published literature. The vendor's website may list client logos, but without third-party validation (case studies, independent reviews, named clinician testimonials), these references are difficult to verify. During procurement, demand contact information for at least three current customers in similar-sized institutions and similar use cases (robotic surgery training, ENT education, remote telementoring). Ask those references about uptime, vendor responsiveness to support tickets, frequency of software updates, and whether promised roadmap features were delivered on schedule.

The roadmap is speculative. The 2023 J Robot Surg study hints at AI-based surgical workflow recognition (automatically labeling procedural phases from video), but no such feature is validated or commercially available as of this review. If the vendor is investing in AI, clarity is needed: What models are being trained? On what datasets? Will AI features require separate FDA clearance? Will they incur additional licensing fees? Buyers should distinguish between the current product (proven video-streaming and annotation) and future aspirations (AI-driven analytics). Contracts should specify which features are included in the base license and which are roadmap-dependent, with clear timelines and remedies if delivery is delayed.

How it compares

Proximie competes most directly with Touch Surgery (now Digital Surgery, owned by Medtronic), which offers procedure guides and VR-based surgical training. Touch Surgery's strength is pre-operative preparation: surgeons rehearse procedures in VR before entering the OR, which complements but does not replace live mentoring. Proximie wins when the use case is intraoperative telementoring (remote expert guiding a live case in real time); Touch Surgery wins when the use case is solo skill-building or standardized procedure rehearsal. Institutions with both training needs might adopt both platforms, but budget-constrained programs must choose: Proximie for live cases, Touch Surgery for asynchronous practice.

Osso VR is another adjacent competitor, focused entirely on immersive VR simulation for orthopedic, robotic, and general surgery. Osso VR's content library is broader (hundreds of procedures), and its enterprise pricing is more transparent (per-learner licensing). However, Osso VR is purely simulation: users train in a virtual environment with no connection to live patient cases. Proximie's advantage is realism: trainees learn on actual cases with real anatomy and real-time decision-making. Osso VR's advantage is safety and repeatability: trainees can practice high-risk steps (vascular control, tissue dissection) without patient harm and can repeat scenarios until mastery is achieved. The two platforms serve complementary roles in a modern surgical training curriculum.

Giblib is a video-library platform with thousands of recorded surgical cases, indexed by procedure type and annotated by expert surgeons. It serves as a Netflix-for-surgery educational resource but lacks live interaction. Proximie's live annotation and telementoring capabilities make it superior for active mentoring during complex cases, while Giblib excels for on-demand learning and case review. A program could use Giblib for foundational learning (watching expert cases, studying technique) and Proximie for live supervision as residents progress to hands-on operating.

OR Black Box (now Surgical Safety Technologies) competes in a different dimension: it records entire OR workflows (video, audio, device data) for post-case safety analysis and complication review. OR Black Box's value proposition is risk management and quality improvement, not training. Proximie could theoretically serve both use cases (live training plus archival review), but its feature set is optimized for the former. Institutions prioritizing patient safety and medicolegal defense might choose OR Black Box; those prioritizing education and remote expertise access would choose Proximie. Both platforms require significant investment, so decision-makers should clarify which problem is more urgent before committing.

What clinicians say

Independent clinician discussion of Proximie is entirely absent from public forums. Zero mentions in r/surgery, r/Residency, or r/medicine subreddits as of May 2025. Zero substantive threads in Doximity's public-facing discussion boards. Zero posts in specialty-specific communities (robotic surgery, ENT, minimally invasive surgery) on Reddit or Sermo. This silence is unusual for a platform that has been commercially available for multiple years and claims adoption in academic medical centers. By comparison, competing platforms like Osso VR generate regular user commentary (both praise for content quality and criticism for cost and technical glitches), and even niche surgical tools like da Vinci robotic consoles have active clinician discussion threads.

The absence of independent clinician voices limits the ability to validate vendor claims about usability, reliability, and satisfaction. Prospective buyers cannot triangulate: Is the platform intuitive for surgeons who are not early adopters? Does video quality degrade during high-bandwidth demand (multiple simultaneous cases)? Do residents perceive the platform as genuinely educational or as performative theater for attending oversight? These questions are best answered by unsolicited clinician feedback, which does not exist in accessible forums. The vacuum forces reliance on vendor-provided references, which are inherently biased toward satisfied customers and away from dissatisfied ones.

This evidence gap is a significant limitation for a review of this depth. Without clinician voices, the review cannot surface real-world pain points, hidden workflow friction, or unexpected benefits that emerge only after sustained use. Buyers should treat the absence of community discussion as a yellow flag, not a deal-breaker: it may indicate limited market penetration, strong vendor NDAs that suppress public commentary, or simply that Proximie users are concentrated in regions or institutions that do not participate in English-language online forums. Regardless of cause, the lack of independent validation increases due-diligence burden. Demand extended pilot periods, insist on direct contact with current users, and build measurable success metrics (training outcomes, case volume, surgeon satisfaction scores) before committing to long-term contracts.

What the literature says

The peer-reviewed evidence base for Proximie consists of five studies published between 2022 and 2024, none of which are randomized controlled trials. The strongest evidence comes from Ann R Coll Surg Engl 2024, an observational study evaluating Proximie for medical student education in ENT surgery. The study found that students using Proximie reported improved visibility of the surgical field, reduced anxiety about the OR environment, and better anatomical understanding compared to traditional in-room observation. However, the study did not measure long-term knowledge retention, procedural competency, or patient outcomes, limiting the strength of the conclusions. The findings are hypothesis-generating rather than definitive.

Two studies (J Robot Surg 2022, Int Braz J Urol 2022) describe Proximie's application in robotic-assisted radical prostatectomy (RARP). The 2022 J Robot Surg study evaluated novice users' ability to learn the platform and found that technical proficiency developed quickly, with most participants comfortable after a single case. The 2022 Int Braz J Urol study described step-by-step optimization of RARP using Proximie's augmented reality features (multi-camera display, live annotation) and noted improved ergonomics for the console surgeon and better spatial orientation for trainees. Both studies are descriptive case series without control groups, making it impossible to isolate Proximie's effect from other training interventions (simulator practice, attending feedback, case volume).

A third study (J Robot Surg 2023) explored video labeling for RARP using Proximie-captured footage and noted the platform's potential role in training AI models for surgical workflow recognition. The study labeled procedural phases (port placement, bladder mobilization, nerve-sparing dissection) and discussed how such datasets could inform machine learning, but no AI model was trained or validated in the study itself. This work is preliminary and aspirational rather than evidence of deployed capability. The final study (Surgeon 2023) is a narrative review of robotic surgery training methods that mentions Proximie alongside simulators, VR platforms, and traditional mentoring but offers no new empirical data. It is cited here for completeness, not for evidentiary weight.

Who it's for

Proximie is purpose-built for academic medical centers and health systems with active surgical training programs. Ideal buyers: institutions with robotic surgery services (urology, gynecology, general surgery) that train residents or fellows; ENT departments with educational missions and limited OR visibility for trainees; community hospitals building new minimally invasive or robotic capabilities who need remote expert guidance during the ramp-up phase; and surgical departments adapting to pandemic-era restrictions or geographic barriers that prevent in-person mentoring. The platform's value scales with training volume: programs running dozens of training cases per month will extract more value than those with sporadic educational activity.

Proximie is not appropriate for primary care clinics, outpatient specialty practices (dermatology, psychiatry, endocrinology), radiology departments, pathology labs, or any non-surgical specialty. It offers no diagnostic support, no EHR integration, and no patient-facing telemedicine capabilities. Even within surgery, its utility is concentrated in specialties with existing video infrastructure: robotic surgery, minimally invasive surgery, endoscopy, and interventional radiology. Open surgery, trauma surgery, and orthopedic cases may derive limited benefit unless the institution invests in additional camera infrastructure to stream overhead views, which adds cost and complexity.

Budget-constrained programs should hesitate. The lack of transparent pricing, the likelihood of five-figure annual commitments, and the need for network upgrades and camera integration make Proximie a significant capital and operational expense. Programs with fewer than two robotic surgery ORs, minimal training volume, or uncertain long-term commitment to surgical education may struggle to justify the investment. Solo community hospitals without academic affiliation should skip Proximie entirely and invest instead in travel funding for surgeons to attend external training courses or in VR simulation platforms (Osso VR, Touch Surgery) that offer lower cost of entry and no infrastructure dependencies. Proximie is a premium tool for institutions where surgical training is a strategic priority and budget is available to support that priority.

The verdict

Proximie addresses a legitimate pain point in surgical education: the visibility gap that limits trainee learning during live cases, and the geographic barriers that prevent remote expert consultation. The platform's technical execution is sound, as evidenced by its documented use in academic centers and its rapid adoption during COVID-19. For institutions with active robotic surgery or ENT training programs, adequate IT infrastructure, and budget flexibility, Proximie is worth serious consideration. The ability to stream multi-camera feeds, annotate in real time, and archive cases for review offers tangible educational value that traditional in-room observation cannot match.

However, the evidence base is alarmingly thin. Five peer-reviewed studies over three years, none of them randomized trials, all concentrated in two specialties (robotic surgery, ENT), constitute preliminary validation at best. The complete absence of independent clinician discussion in online forums eliminates a critical source of real-world performance data. The pricing opacity, hidden implementation costs, and lack of public compliance documentation (HIPAA, SOC 2, FDA status) shift substantial due-diligence burden to the buyer. These are not disqualifying flaws, but they demand caution: pilot before committing, measure outcomes rigorously, and negotiate contract terms that allow exit if performance underdelivers.

Decision rules: If you are a large academic medical center with a robust robotic surgery program, a dedicated surgical training budget, and IT infrastructure capable of supporting high-bandwidth OR streaming, pilot Proximie over six to twelve months with clearly defined success metrics (trainee satisfaction scores, procedural competency assessments, reduction in attending travel costs for remote mentoring). If the pilot demonstrates measurable value and vendor support is responsive, a multi-year contract is defensible. If you are a community hospital, a small surgical program, or a budget-constrained institution, defer investment in Proximie and allocate resources instead to lower-cost, higher-evidence alternatives like Osso VR (for VR simulation), Giblib (for video-based learning), or direct funding for attending surgeon travel to provide in-person mentoring. Proximie is a specialized tool for a narrow use case. Within that niche, it performs well. Outside that niche, it offers no value. Know which category your institution occupies before engaging with the vendor.